Reactive oxygen species have been established as key mediators of cardiac injury following ischemia/reperfusion (I/R). We hypothesized that superoxide formation at different subcellular locations following cardiac I/R injury may differentially regulate cellular responses that determine pathophysiologic outcomes. Recombinant adenoviruses expressing Cu/ZnSOD or MnSOD were utilized to modulate superoxide levels in the cytoplasmic or mitochondrial compartments, respectively, prior to coronary artery I/R injury in the rat heart. Ectopic expression of both MnSOD and Cu/ZnSOD afforded protection from I/R injury, as evidenced by a significant reduction in serum creatine kinase levels, infarct size, malondialdehyde levels, and apoptotic cell death in comparison to controls. MnSOD and Cu/ZnSOD expression also significantly altered the kinetics of NFB and AP-1 activation following I/R injury, characterized by a delayed induction of NFB and abrogated AP-1 response. Western blot analysis of Bcl-2, Bcl-xL, Bad, Caspase 3, PDK1, and phospho-Akt also revealed SOD-mediated changes in gene expression consistent with protection and decreased apoptosis. These findings support the notion that both mitochondrial and cytoplasmic-derived SOD induce changes in AP-1 and NFB activity, creating an antiapoptotic microenvironment within cardiomyocytes that affords protection following I/R injury.
INTRODUCTION
Ischemia/reperfusion (I/R) injury to the heart is a pathophysiologic consequence often associated with several common clinical procedures (e.g., thrombolysis, angioplasty, and coronary bypass surgery). Oxidative stress, caused by the production of excess reactive oxygen species (ROS) during reperfusion, is one of the main mechanisms proposed to explain I/R pathogenesis. The excess formation of ROS, including superoxide anion (
• O 2 Ϫ ), hydrogen peroxide (H 2 O 2 ), and hydroxyl radical (
• OH), following I/R can lead to direct oxidative damage of DNA, mitochondria, proteins, and lipids and contributes to necrosis in the ischemic zone. ROS can also regulate redoxsensitive signal transduction pathways, including NFB and AP-1, which may be involved in programmed cell death (apoptosis) or in promoting cell survival [1] [2] [3] [4] . Both necrosis and apoptosis contribute to the total cell death incurred during I/R, with apoptosis accounting for 50% or more [5, 6] . NFB is known to suppress apoptosis in ventricular myocytes and plays an essential role in ischemic preconditioning in the heart [7, 8] . The protective role of NFB in preconditioning appears to be associated with the induction of Bcl-2, a component of an antiapoptotic pathway [9, 10] . However, it is not clear whether AP-1 promotes apoptosis or cell survival [9, 11] . Following myocardial I/R, dramatic increases in ROS formation are found in both the mitochondria and the cytoplasm of cardiomyocytes [12] . Superoxide dismutase (SOD), a family of enzymes that catalyze the dismutation of superoxide anions into hydrogen peroxide, has two primary intracellular isoforms: Cu/ZnSOD, localized mainly in the cytoplasm, and MnSOD, which is found in mitochondria [13] . Both Cu/ZnSOD and MnSOD have been reported to protect against cardiac I/R injury in transgenic mice [14, 15] ; however, the distinct roles of these two isoforms following I/R have been reported in other organ systems [16, 17] . For example, in the liver, it has been shown that MnSOD is protective from I/R injury while Cu/ZnSOD is not [17] . Although the ability of Mn-SOD and Cu/ZnSOD to protect the heart from I/R injury has been previously demonstrated in several model systems [14, 15, 18, 19] , the pathophysiologic responses to I/R controlled by superoxide production and modulated by SOD in cardiomyocytes remain unclear.
The development of gene therapy techniques that can deliver ROS-modulating genes to the heart is potentially a very powerful tool both for investigating the molecular events involved in myocardial (I/R) injury and for developing new therapeutic approaches. The current study utilizes recombinant adenoviral vectors, encoding either Cu/ ZnSOD or MnSOD, in a rat model of cardiac I/R injury. This approach was used to investigate the relative ability of these two enzymes to protect the myocardium from I/R injury and to determine their effect on the signaling pathways that contribute to cardiac injury or survival.
RESULTS

Recombinant Adenoviral Vectors Mediate Highly Efficient Cu/ZnSOD or MnSOD Transgene Expression in the Rat Heart
To establish the parameters for gene delivery to the heart, we first performed experiments evaluating the efficiency and distribution of GFP transgene expression using an Ad.GFP reporter vector. The optimal gene delivery method utilized brief occlusion of the pulmonary artery and aorta to allow for coronary artery infusion of vector delivered into the left ventricle. This method produced high levels of transgene expression (ϳ80%) in the area at risk (AAR) of our ischemic model that peaked by 7 days and gradually declined 2 weeks after the initial infection (Fig. 1A) . The decline in transgene expression at 14 -21 days was associated with T cell infiltrates and clearance of virally infected cells (data not shown). Infection of the heart with Ad.Cu/ZnSOD or Ad.MnSOD demonstrated a sixfold increase in SOD transgene expression in the AAR compared to baseline (PBS infusion or Ad.BglII-infected control hearts), as detected by native polyacrylamide ingel enzyme assays (Fig. 1B ). These results demonstrate that adenovirally encoded transgenes can effectively be used to manipulate genetically the majority of the AAR prior to I/R injury.
Recombinant Adenovirally Expressed MnSOD and Cu/ZnSOD Correctly Localize to Their Native Subcellular Compartments in Cardiac Cells
Since a goal of this study was to discern potential functional differences in the I/R response that were facilitated by SOD expression in the mitochondria and cytoplasm, we next sought to confirm that overexpressed Cu/ZnSOD or MnSOD maintained its normal pattern of subcellular localization. To this end, we performed immunofluorescence colocalization studies on a rat cardiac cell line (H9C2) following infection with either Ad.MnSOD or Ad.Cu/ZnSOD. In these studies, expression of human Mn-SOD in H9C2 cells demonstrated absolute colocalization with a mitochondrial marker (Fig. 2) . In contrast, adenovirally expressed human Cu/ZnSOD was detected solely in the cytoplasm and did not colocalize with the mitochondria (Fig. 2 ). These results demonstrate that Ad.Cu/ ZnSOD and Ad.MnSOD can express their respective transgenes in the correct subcellular compartments. Hence, these transgenes can be used to discern how mitochondrial and cytoplasmic superoxides control molecular events following I/R injury in the heart.
Ectopic Expression of Either Cu/ZnSOD or MnSOD
Reduces Serum Creatine Kinase (CK) Levels and Malondialdehyde (MDA) Levels in the Heart Following I/R We next sought to determine whether overexpression of MnSOD and/or Cu/ZnSOD in the heart prior to I/R injury could afford cardiac protection. Two endpoints, serum CK levels and MDA measurement of heart tissue, were used as indexes of necrotic cardiac damage and oxidative stress, respectively. Five groups of animals were evaluated in these studies, including: (1) sham-operated without I/R, (2) PBS-infused with I/R, (3) Ad.BglII-infected with I/R, (4) Ad.Cu/ZnSOD-infected with I/R, and (5) Ad.MnSOD-infected with I/R. Serum CK and MDA levels were evaluated prior to I/R and at 1, 3, and 5 h post-I/R. Results from these studies demonstrated no significant differences between baseline and 1-h post-I/R levels of serum CK among all groups of animals. However, both Ad.Cu/ZnSOD and Ad.MnSOD afforded a significant reduction in serum CK at both 3 and 5 h post-I/R, compared to PBS or Ad.BglIIinfected control groups (Fig. 3A) . The greatest level of reduction (fivefold) was seen at 5 h post-I/R and was equivalent for both MnSOD and Cu/ZnSOD (P Ͻ 0.001, n ϭ 10 for each group) (Fig. 3A) . Results from MDA analysis demonstrated several intriguing findings. First, baseline MDA levels prior to I/R injury were significantly reduced for both Cu/ZnSOD and MnSOD compared to all other groups (Fig. 3B) . Second, control PBS-infused and Ad.BglII-infected hearts demonstrated a rise in cardiac MDA levels that peaked at 1 h post-I/R and returned to near baseline levels by 5 h. This rise in post-I/R MDA levels was significantly attenuated by Cu/ZnSOD or MnSOD expression (Fig. 3B) . However, MnSOD expression appeared to afford a larger level of protection from post-I/R oxidative stress than Cu/ZnSOD, the difference being most significant at the 3-h post-I/R time point. These findings suggest that although enhanced clearance of superoxides in either the cytoplasm or the mitochondria reduces the oxidative stress in the heart following I/R, mitochondrialderived superoxides may play a dominant role in post-I/R oxidative stress. 
Both Cu/ZnSOD and MnSOD Expression Significantly
Reduces Infarct Size Following Cardiac I/R Injury Infarct size, as determined by Evan's blue and 2,3,5-triphenyltetrazolium chloride (TTC) staining, was used to evaluate the extent of gross structural damage to the heart at both 5-h and 4-day post-I/R time points. Results from these experiments demonstrated that infarct size (as the percentage infarct in the AAR) was significantly reduced (four-to fivefold) at 5 h post-I/R in both Ad.Cu/ZnSOD (17.6 Ϯ 5.1%) and Ad.MnSOD (16.9 Ϯ 7.2%)-infected groups compared to PBS (78.2 Ϯ 11.8%) or Ad.BglII (89.6 Ϯ 9.4%)-infected controls (P Ͻ 0.001, n ϭ 10 for each group) (Figs. 4A and 4C ). Similarly, a four-to fivefold reduction in infarct size was achieved in both Ad.Cu/ ZnSOD (16.1 Ϯ 2.5%) and Ad.MnSOD (15.2 Ϯ 6.3%)-infected rats compared to PBS (72.4 Ϯ 14.9%) or Ad.BglII (79.3 Ϯ 5.7%)-infected controls at 4 days post-I/R (P Ͻ 0.001, n ϭ 4 for each group) (Figs. 4B and 4D ). There was no significant difference in the size of the AAR in the four groups as determined by the relative area of Evan's blue dye exclusion in the heart (Figs. 4C and 4D ). These findings suggest that enhanced superoxide clearance in either the cytoplasm or the mitochondria reduces both acute and long-term I/R damage to the heart. MnSOD or Cu/ZnSOD Expression Attenuates Apoptosis in the Heart Following I/R Injury Programmed cell death, arising from the activation of proapoptotic signal transduction pathways, reportedly accounts for at least half of the total cell destruction during myocardial I/R [5, 6] . It has also been reported that regulation of the cellular redox environment and apoptosis following cardiac I/R are primarily controlled by the mitochondria [20, 21] . To this end, we hypothesized that the mechanisms of protection afforded by Cu/ZnSOD or Mn-SOD overexpression may be different. We reasoned that necrosis (i.e., direct cellular injury), promoted by cytoplasmic superoxide production following I/R, might be more significantly influenced by Cu/ZnSOD expression. In contrast, we hypothesized that MnSOD expression might more significantly attenuate I/R-induced apoptosis. To differentiate between protective effects against necrosis from those affecting apoptosis, we evaluated directly the extent of apoptosis using the TUNEL method. To distinguish between potential cell types in the heart that may undergo apoptosis following I/R, we used desmin as a cardiomyocyte-specific marker. We quantified the percentage of cardiomyocytes and other cell types that were apoptotic at 5 h post-I/R in the following five groups: sham-operated no I/R, PBS I/R, Ad.BglII I/R, Ad.Cu/Zn-SOD I/R, and Ad.MnSOD I/R. In contrast to our original hypothesis, these studies demonstrated a seven-to ninefold reduction in the percentage of apoptotic cardiomyocytes within the AAR in both Ad.Cu/ZnSOD (1.27 Ϯ 0.62%) and Ad.MnSOD (1.11 Ϯ 0.48%)-infected hearts compared to PBS (8.54 Ϯ 1.44%) or Ad.BglII (10.12 Ϯ 2.32%)-infected controls (Fig. 5 ). Similar reductions (sixto sevenfold) were seen in the percentage of total apoptotic cells within the AAR in both Ad.Cu/ZnSOD (4.32 Ϯ 2.36%) and Ad.MnSOD (3.87 Ϯ 1.87%)-infected hearts compared to PBS (22.7 Ϯ 4.37%) or Ad.BglII (26.44 Ϯ 5.87%)-infected controls. These results suggest that superoxides in both the cytoplasm and the mitochondria play an important role in apoptotic cell death of cardiomyocytes and other cell types in the heart following I/R injury.
SOD Gene Overexpression Modulates Cardiac NFB and AP-1 Responses Following I/R Injury
Following I/R injury to the heart, both AP-1 and NFB are induced at high levels. This is consistent with many reports demonstrating that these signaling pathways are redox regulated [1] [2] [3] [4] . To evaluate whether SOD expression was capable of modulating either NFB and/or AP-1 activity, we performed electrophoresis mobility shift assays (EMSA) on nuclear extracts prepared from AAR tissues following 1 h of ischemia and 1-5 h of reperfusion. Results from these experiments demonstrated that Mn-SOD and Cu/ZnSOD significantly alter the kinetics of NFB and AP-1 induction. The induction of AP-1 following I/R was blunted and delayed in Ad.Cu/ZnSOD and Ad.MnSOD-infected groups compared to PBS or Ad.BglIIinfected controls (Fig. 6) . Additionally, AP-1 induction demonstrated a bimodal induction pattern at both 1 and 5 h in controls, but had a single 3-h peak in Ad.Cu/ ZnSOD-and Ad.MnSOD-infected groups. In contrast, Cu/ ZnSOD and MnSOD expression significantly delayed the induction of NFB compared to control groups. However, peak levels in Ad.Cu/ZnSOD-and Ad.MnSOD-infected groups at 5 h were similar to those seen in control groups at 3 h post-I/R (Fig. 6 ). These results suggest that enhanced superoxide clearance in both the mitochondria and the cytoplasm appear to have similar effects on the temporal regulation of NFB and AP-1 in the acute phases of I/R injury. Furthermore, given the protective effects of SOD expression, the results also suggest a potential link between transcriptional modulation of factors that determine cell fates in the heart following I/R injury.
Overexpression of MnSOD-or Cu/ZnSOD-Regulated Signaling Molecules Involved in Apoptosis and Cell Survival
Bcl-2, Bcl-xL, Bad, and Mcl-1 are among the Bcl-2 family of proteins that regulate mitochondrial-initiated apoptosis and/or cell survival pathways. In contrast, Caspase 3 lies downstream of mitochondria as a primary effector caspase that regulates apoptosis and can also be activated directly by a number of receptor-initiated pathways.
FIG. 3.
Expression of Cu/ZnSOD or MnSOD reduces serum creatine kinase and malondialdehyde levels in the heart following I/R injury. (A) Serum samples were assayed for creatine kinase activity in the indicated four experimental groups at the following time points: before I/R and 1, 3, and 5 h post-I/R injury. At the time points of 3 and 5 h post-I/R, both Ad.Cu/ZnSOD and Ad.MnSOD afforded a significant reduction, compared to PBS or Ad.BglII-infected control groups. (B) Tissue samples from the AAR were assayed for MDA activity in the indicated four experimental groups at time points before I/R and at 1, 3, and 5 h post-I/R. The relative changes in MDA levels were assessed in comparison to sham-operated hearts that did not receive I/R injury (baseline MDA levels are indicated by the dotted line). Data represent the means (ϮSEM) of n ϭ 10 independent animals in each group for the CK assay and n ϭ 4 independent animals in each group for the MDA assay. † Statistically significant difference (P Ͻ 0.001) compared to the PBS or Ad.BglII-infected group using the Student t test.
PDK1 (phosphoinositide-dependent kinase 1), Akt, and PKCε function at cytoplasmic sites and are also known to regulate directly apoptosis, cell survival, and/or NFB activation. Using Western blotting, we compared the abundance of these mitochondrial and cytoplasmic proteins in control non-I/R hearts and I/R-treated hearts infected with PBS, Ad.BglII, Ad.Cu/ZnSOD, or Ad.MnSOD (Fig.  7A) . Quantification in these studies was performed relative to actin as an internal control for protein loading. Significant elevations (P Ͻ 0.05, n ϭ 4 for each group) in phosphoSer473-Akt-1, Mcl-1, Bad, PDK1, Caspase 3, and Bcl-xL were seen in PBS or Ad.BglII-infected animals compared to sham-operated controls. Several notable similarities and differences were seen in the expression patterns of these proteins in Ad.Cu/ZnSOD-and Ad.MnSOD-infected tissues (Fig. 7B) . Both Cu/ZnSOD and MnSOD significantly reduced Bad and Caspase 3 expression (P Ͻ 0.05, n ϭ 4 for each group) compared to PBS or Ad.BglIIinfected controls. These findings are consistent with the known proapoptotic roles of Caspase 3 and Bad [22] and the reduced apoptosis demonstrated herein with both of these SOD isoforms. Similarly, PDK1 and Bcl-xL were also significantly reduced in both MnSOD-and Cu/ZnSODexpressing animals (P Ͻ 0.05, n ϭ 4 for each group). Significant increases (P Ͻ 0.05, n ϭ 4 for each group) in phosphoSer473-Akt-1 and Bcl-2 levels were seen in Ad.Cu/ZnSOD-and Ad.MnSOD-infected tissues compared to PBS or Ad.BglII. Ad.MnSOD or Ad.Cu/ZnSOD infection, in comparison to the PBS or Ad.BglII group, invoked no significant alterations in the expression of PKCε or the nonphosphorylated form of Akt-1. Although the trends were similar for both MnSOD-and Cu/ZnSODexpressing hearts, MnSOD more significantly reduced Caspase 3 and Bcl-xL.
DISCUSSION
Using recombinant adenoviruses to manipulate the redox microenvironment in the mitochondrial and cytoplasmic compartments, the present study has attempted to define more precisely the involvement of superoxides in myocardial I/R injury and their relationship to signaling pathways controlling apoptosis and cell survival. No previous studies have directly compared the efficacy of MnSOD and Cu/ZnSOD overexpression in attenuating cardiac I/R injury. Our findings are in agreement with the protective effects seen in MnSOD-or Cu/ZnSOD-overexpressing transgenic mice [14, 15] and adenoviral-mediated MnSOD expression in rat hearts [18, 19] . However, in these previous studies, only functional indexes of protection (i.e., postischemic contractility and/or infarct size) from cardiac I/R injury were evaluated. To investigate further the potential mechanisms responsible for MnSOD-and Cu/ ZnSOD-mediated protection from I/R injury in the heart, we have evaluated how MnSOD or Cu/ZnSOD expression alters redox-regulated molecular responses to I/R injury that can influence cardiomyocyte survival and apoptosis. We hypothesized that functional differences in MnSODor Cu/ZnSOD-mediated protection from cardiac I/R may arise from their distinct subcellular localization and abilities to modulate the redox state of the mitochondria or cytoplasm, respectively. Importantly, our findings confirmed that adenovirally expressed human MnSOD was specifically localized to the mitochondria while overexpression of human Cu/ZnSOD was limited to the cytoplasm. These findings support the correct subcellular partitioning of these adenovirally expressed SOD isoforms in hepatocytes and epithelial cells [17, 23, 24] .
Previous studies using purified SOD and catalase protein have demonstrated that these proteins can significantly reduce the extent of oxidative stress following cardiac I/R as determined by MDA levels [25] . Furthermore, this reduction in I/R-induced MDA by SOD and catalase was correlated with an inhibition of apoptosis. However, in this previous study, SOD and catalase were exogenously applied to ex vivo perfused hearts. To investigate whether intracellular expression of MnSOD or Cu/ZnSOD could also protect from I/R-induced oxidative stress, we similarly examined MDA levels in our various experimental groups. Interestingly, nonischemic animals expressing either MnSOD or Cu/ZnSOD in the heart demonstrated a significantly reduced baseline level of MDA compared to PBS-infused or Ad.BglII-infected control hearts. These findings suggest that enhanced clearance of superoxides in either the mitochondria or the cytoplasm can attenuate oxidative stress in nonischemic hearts. Similarly, both MnSOD and Cu/ZnSOD also reduced the peak MDA levels seen in I/R-injured hearts, although MnSOD was slightly more effective. From these studies, we conclude that mitochondria may be a predominant source of redox stress in the heart following I/R injury. Compared to previous studies using exogenously-applied SOD and catalase proteins also capable of reducing I/R-induced MDA accumulation [25] , these results suggest that both intracellular and extracellular ROS may play important roles in I/R responses. The observed reduction in oxidative stress afforded by MnSOD and Cu/ZnSOD expression correlated directly with a four-to fivefold protection of the heart from infarct damage at both 5 h and 4 days following I/R. These findings, which for the first time directly compared MnSOD and Cu/ZnSOD, suggest that both SOD isoforms can significantly reduce post-I/R oxidative stress and similarly protect the heart from redox-mediated damage.
Programmed cell death arising from the activation of proapoptotic signal transduction pathways reportedly accounts for at least half of the total cell destruction during myocardial I/R [5, 6] . Our studies, demonstrating ϳ25% total cellular apoptosis and ϳ10% cardiomyocyte apoptosis in the AAR following I/R-induced injury of vehicletreated and Ad.BglII-infected animals, are in agreement with these previous findings. In accordance with infarct studies, Cu/ZnSOD or MnSOD expression significantly ARTICLE doi:10.1016/S1525-0016(02)00061-8 reduced (six-to ninefold) total cell and cardiomyocyte apoptotic death. Based on these findings, we further focused our mechanistic studies on I/R-induced pro-and antiapoptotic signal transduction pathways. We evaluated the activation of two well-known redox-regulated transcription factors, NFB and AP-1 [26] . NFB induction appears to be essential for the cardiac-protective effects of ischemic preconditioning [27] . Furthermore, an inverse correlation between changes in NFB (increased) and AP-1 (decreased) activity following ischemic precondi- . The fractional percentage of the infarct area (white regions)/ischemic area (red ϩ white regions) is representative of the extent of damage following I/R injury and takes into account the slight variability in the size of the AAR (non-blue region). Data represent the means (ϮSEM) for n ϭ 10 independent animals in each group for 5 h post-I/R experiments and n ϭ 4 independent animals in each group for 4 days post-I/R experiments. † Statistically significant difference (P Ͻ 0.005) compared to the PBS or Ad.BglII-infected group using the Student t test.
tioning has been hypothesized to regulate transcription of genes (Bcl-2 and p53) that enhance biologic resistance to I/R [11] . In our study, overexpression of either Cu/ZnSOD or MnSOD resulted in a delayed and reduced activation of AP-1 following I/R. Although NFB activation following I/R was also delayed by Cu/ZnSOD or MnSOD expression, at later time points, its activation was enhanced above that seen in vehicle-treated and Ad.BglII-infected controls. Our findings that the protective effects of MnSOD and Cu/ZnSOD correlate with increased NFB activity and decreased AP-1 appear to be strikingly similar to findings in ischemic preconditioning models [11, 26, 27] . This similarity suggests that the protection afforded by MnSOD and Cu/ZnSOD expression may be due to redox-dependent alterations in the temporal regulation of AP-1 and NFB, which provide a more protective environment that is conducive to cell survival following I/R.
Bcl-2 upregulation in ischemic preconditioned hearts has been associated with protection from cardiac I/R injury [11, 26, 27] and is thought to be facilitated by increased NFB activation and decreased AP-1 activation caused by ischemic adaptation [10, 11, 26] . We therefore investigated whether the level of Bcl-2 and other apoptotic factors might be altered by MnSOD and Cu/ZnSOD expression. In agreement with the hypothesis that Mn-SOD and Cu/ZnSOD function similarly as in ischemic preconditioning to protect the heart from apoptotic injury following I/R, we observed significantly enhanced levels of Bcl-2 in hearts expressing both isoforms of SOD. In contrast, vehicle control and Ad.BglII-infected hearts demonstrated a decrease in Bcl-2 expression compared to sham (no I/R) controls, in agreement with previous studies [11] . The finding that NFB and AP-1 differentially regulate Bcl-2 activity is consistent with our findings that both Cu/ZnSOD and MnSOD induce NFB and Bcl-2 while reducing AP-1 activation following I/R injury in the heart.
Other apoptotic factors altered by I/R injury in vehicleinjected and Ad.BglII-infected control hearts included a significant upregulation of PDK1, Bcl-xL, Mcl-1, Bad, and Caspase 3 compared to sham-operated control hearts. All of these factors, with the exception of Mcl-1, were significantly reduced by either MnSOD or Cu/ZnSOD expression. Despite these similarities in MnSOD-and Cu/Zn-SOD-facilitated alterations in the abundance of apoptotic factors, several subtle differences were observed in the † Statistically significant difference (P Ͻ 0.05) compared to the PBS infusion or Ad.BglII-infected group using the Student t test. *Statistically significant difference (P Ͻ 0.05) compared to the nonischemic control group using the Student t test. All blots were reprobed for actin as an internal reference for protein loading and all values represent levels normalized to actin signal. ARTICLE doi:10.1016/S1525-0016(02)00061-8 magnitude of these changes. For example, I/R-induction of Bcl-xL and Caspase 3 was completely abolished by ectopic expression of MnSOD, but not by Cu/ZnSOD. This finding is similar to those demonstrating a decrease in Bcl-xL expression levels in an MnSOD-transfected cell line [28] and suggests differential roles for cytoplasmic and mitochondrial superoxides in controlling Bcl-xL expression. However, since Bcl-xL is recognized as an antiapoptotic factor, the functional significance of MnSOD-induced changes in Bcl-xL expression remains unclear. Another intriguing finding was the significant reduction in PDK1 levels in both Ad.MnSOD-and Ad.Cu/ZnSODtransduced animals compared to PBS or Ad.BglII-transduced controls. PDK1 is known to mediate the phosphorylation of a number of proteins, including Akt, p70 S6 , kinase, PKA, and PKC [29 -31] , all of which have been demonstrated to be important in ischemic injury. Furthermore, since constitutively active Akt has been shown to protect cardiomyocytes from hypoxic-induced injury [32] , our findings demonstrating increased levels of the phosphorylated active form of Akt in SOD-expressing hearts are in agreement with the decreased levels of apoptosis observed following I/R. Although decreased levels of PDK1 appear to contrast with the increased Akt phosphorylation observed in SOD-expressing hearts, it is important to point out that the absolute level of a kinase does not directly correlate with its activity. Hence, the alterations in the steady-state level of PDK1 must be interpreted in that context.
Both membrane and mitochondria-initiated pathways participate in I/R-induced apoptosis and the generation of ROS [13, 33, 34] . Our results, demonstrating protection from cardiac I/R injury following ectopic expression of MnSOD or Cu/ZnSOD, substantiate previous findings that illustrated a link between superoxide generation and the control of apoptotic pathways. Using multiple molecular endpoints, our studies demonstrated a striking similarity between MnSOD and Cu/ZnSOD in their ability to modulate AP-1, NFB, and many apoptotic factors following cardiac I/R, despite their distinct locations within the cell. One potential hypothesis, which might explain how enhanced superoxide clearance in both the mitochondria and the cytoplasm provides similar protective effects, is the notion that mitochondria are the major source of ROS production following I/R that acts on components in the cytoplasm to transduce signals. In such a scenario, Mn-SOD expression would reduce activation of superoxidemediated signals by preventing its spread to the cytoplasm. Similarly, in the presence of Cu/ZnSOD expression, superoxides originating from the mitochondria, but acting on factors in the cytoplasm, could also be inhibited. In support of such a hypothesis, regulation of the cellular redox environment and control of apoptosis following cardiac I/R have been suggested to be primarily controlled by the mitochondria [21, [35] [36] [37] [38] . In contrast, if superoxide production by NADPH oxidase at the cellular membrane is the predominant source of ROS following I/R, one would have expected Cu/ZnSOD expression to be more effective than MnSOD at modulating such an I/R response. Our studies are also consistent with the hypothesis that ROS production is initiated at the cellular membrane and amplified by mitochondria, a scenario also expected to be altered by both MnSOD and Cu/ZnSOD expression. Further investigation into these potential mechanisms of MnSOD and Cu/ZnSOD action following I/R will enhance our understanding of redox-mediated control of apoptosis in the heart and aid in the development of more efficacious therapeutic approaches for ischemic heart disease.
METHODS
Recombinant adenoviruses. Four recombinant E1-deleted adenoviral vectors, Ad.BglII, Ad.GFP, Ad.MnSOD, and Ad.Cu/ZnSOD, expressing their transgenes from the CMV promoter/enhancer, were used in this study. Ad.BglII (empty vector control) and Ad.GFP were both provided by the University of Iowa Vector Core. Ad.MnSOD and Ad.Cu/ZnSOD have been previously described [23] . Recombinant adenoviral stocks were generated as previously described [39] and were desalted by gel filtration in PBS on a Sephadex G-50 column prior to use.
I/R injury model and in vivo adenoviral transduction. Male Wistar rats (250 -300 g) were used in a coronary artery ischemia/reperfusion model [40] . Gene transfer with recombinant adenovirus was performed prior to ligature placement around the left anterior descending (LAD) coronary artery. To facilitate gene transfer, the pulmonary artery was clamped, and the aorta was temporarily occluded (ϳ15 s) while 200 l of recombinant adenovirus vector (total 2 ϫ 10 11 particles) was injected into the left ventricle chamber to facilitate coronary artery infusion under high pressure. The number of particles experimentally determined to give maximal gene expression with minimum toxicity as measured by the rise in baseline CK at 3 days post-adenoviral gene transfer to the heart was 2 ϫ 10 11 (data not shown). The I/R protocol was performed at 3 days postinfection and included 1 h of coronary artery occlusion, followed by 1, 3, and 5 h or 4 days of reperfusion. Histopathologic examination of ischemic and infarct size was determined using a previously described [41] method to demarcate the AAR and infarct region using Evan's blue dye and TTC staining. Briefly, at the end of postreperfusion, the LAD coronary artery was religated at the same position. Following injection of Evan's blue into the left ventricle, the heart was removed and perfused with 1ϫ PBS at room temperature and then directly frozen en bloc in liquid nitrogen for storage at Ϫ80°C. At the time of analysis, the heart tissue was warmed in a Ϫ20°C freezer for 2 h and sectioned transversely (1 mm), followed by staining in 1% TTC at 37°C for 20 min. To stop the staining, the tissue was rinsed in 10% neutralized formalin for 12 h and then weighed and visualized with a digital camera to determine the fraction of each section with blue, red, or white staining. The AAR was determined as the percentage of red plus white in relation to the total area (red plus white plus blue). Infarct size was determined as the percentage of white compared to the total area of white plus red. The nonischemic region, ischemic region (AAR), and infarct region were quantified by computer planimetry using NIH Image (v1.62). Calculations were averaged over all sections from each heart, and the contribution of each section was corrected by its wet weight.
ECG monitoring and measurement of serum CK. A Burdick
M EK/5A recorder was used for the ECG monitoring during I/R. An elevation or depression (depending on the lead placement) of ST-T waves was taken to indicate experimental ischemia after tightening of the coronary ligature. Normalization of ST-T waves indicated experimental reperfusion after the sutures were released. These two criteria were used for all animals to ensure proper functioning of the occluding and releasing sutures. Serum CK levels were measured using a kit following the manufacturer's instructions with modifications (Sigma-Aldrich, St. Louis, MO). Blood samples (ϳ50 l) were collected via the tail vein prior to ischemia and post-I/R, and the serum was collected by centrifugation. Ten microliters of serum was dispersed into 96-well microplates, followed by the addition of 250 l of the A/B reagent mixture. The plate was then moved to a prewarmed sample chamber in a microplate reader (Molecular Devices, Sunnyvale, CA). After 3 min of incubation and mixing, readings were made at 1, 2, and 3 min. The CK serum levels were calculated based on the rate of change in the OD.
Spectrophotometric assay for MDA. The concentration of MDA in the heart tissues was used as an indicator for oxidative stress. MDA was measured using the Bioxytech MDA-586 kit (Oxis Research, Portland, OR) following the manufacturer's protocols with the following modifications. Briefly, 100 mg of heart tissue from the ischemic area (AAR as marked by exclusion of Evan's blue dye perfusion) was homogenized in 300 l of ice-cold lysis buffer containing 0.05% deoxycholic acid, 0.1% Triton X-100, 5 mM butylated hydroxytoluene in 0.9% NaCl. Sample homogenates were then centrifuged at 3000g for 10 min at 4°C and the supernatant was used for subsequent assays. Protein concentration was determined using the Bradford method. One milligram of protein from each sample was mixed with 210 l of lysis buffer and 5.3 l of concentrated HCl and incubated at 60°C for 80 min. Six hundred eighty microliters of diluted reagent R1 was then added and centrifuged at 13,000g for 5 min. The supernatant was transferred to new tubes and incubated with 115 l of reagent R2 at 45°C for 60 min. The tubes were then centrifuged at 13,000g for 5 min. Finally, the supernatant was measured in a spectrophotometer at 586 nm and concentrations of MDA were calculated using standards. The relative change in MDA levels for each experimental groups was assessed in comparison to control sham-operated hearts that did not receive I/R injury.
Terminal transferase UTP nick-end labeling (TUNEL), anti-desmin antibody labeling, and DAPI staining for detection and quantification of apoptotic cardiomyocytes. A triple-fluorescence-based staining was utilized for quantification of apoptotic cells in the heart. These studies utilized anti-desmin antibody staining to mark cardiomyocytes, DAPI staining to mark nuclei, and TUNEL staining to mark apoptotic nuclei. Following I/R injury, transverse sections of the apex to the atrioventricular groove (1 mm thick) were paraffin embedded. Ten-micrometer paraffin sections were dehydrated for antigen retrieval and permeabilized by placement in 10 mM citrate buffer for 60 min at 60°C. Sections were then washed three times in Tris-buffered saline (TBS) and stained for desmin using an anti-desmin antibody (1:50 dilution, monoclonal mouse antihuman desmin; DAKO Corp., Carpinteria, CA) at room temperature for 60 min. A secondary antibody, Alexa Fluor 594 goat anti-mouse IgG (1:50; Molecular Probes, Eugene, OR) was used to visualize the desmin. TUNEL staining was then performed on each section as follows. Fifty microliters of TUNEL mixture, containing TdT and dUTP in reaction buffer, was placed onto each section (Roche Molecular Biochemicals, Basel, Switzerland) and incubated in the dark in a humidified chamber for 60 min at 37°C. After the slides were rinsed three times in TBS, they were mounted with DAPI mounting medium (Vector Laboratories, Inc., Burlingame, CA) to visualize the nuclei. Samples were analyzed by fluorescence microscopy using rhodamine, FITC, and UV channels. Apoptosis was quantified in the AAR from all experimental conditions and classified as percentage apoptotic desmin-positive (i.e., cardiomyocytes) and non-desmin-positive cells using DAPI to demarcate all nuclei in a given field. The numbers of sections analyzed for each sample are given the figure legends.
EMSA and Western blots. Nuclear and cytoplasmic proteins were extracted from the nonischemic and AAR regions of the heart using a kit from Pierce (Rockford, IL). Briefly, 100 mg of heart tissue was homogenized in 500 l of ice-cold buffer CER I, mixed with 27.5 l of ice-cold CER II buffer, and incubated on ice for 1 min. The cytoplasmic fraction was collected as the supernatant following centrifugation. The nuclear fraction was collected by resuspending the pellet in 100 l of ice-cold NER buffer with vortexing and then centrifugation. The Bio-Rad protein assay (Hercules, CA) was used to measure the protein content of each fraction. EMSA was performed as described [17] using 6 g of nuclear extract and the following nucleotide sequences: NF-B, 5Ј-AGTTGAGGGGACTTTC-CCAGGC-3Ј; AP-1, 5Ј-CGCTTGATGAGTCAGCCGGAA-3Ј (Promega, Madison, WI). For Western blotting, 40 g of protein from the cytoplasmic fractions derived from the AAR was analyzed as described [17] . Primary antibodies against cell apoptosis/survival-related proteins were purchased from Upstate Biotechnology, Inc. (phosphoSer473-Akt1) and BD Transduction Laboratories (Caspase 3, PDK1, Akt, Bcl-2, Bcl-xL, Mcl-1, PKC⑀, and Bad). Actin immunoreactivity, detected using an anti-actin antibody (Santa Cruz Biotechnology, Santa Cruz, CA) was used as an internal control for loading. The antibodies were diluted according to the manufacturers' recommendations. Immunoreactivity was visualized using HRPconjugated secondary antibodies with ECL detection. Bands on Western blots and EMSA were quantified by densitometry using NIH Image software.
Detection of SOD activity in transduced rat hearts. In-gel activity assays were used to evaluate Cu/ZnSOD and MnSOD activity from hearts transduced and infused in PBS or infected with Ad.BglII, Ad.MnSOD, or Ad.Cu/ ZnSOD [24] . Briefly, 200 g of homogenized tissue protein from the AAR was separated in a native acrylamide gel. The gels were stained in SOD activity reaction buffer (2.45 mM NBT, 2.8 ϫ 10 Ϫ5 M riboflavin, 28 mM TEMED in distilled water) (Sigma). To selectively stain for MnSOD, 0.75 mM NaCN was included in the reaction buffer to inhibit Cu/ZnSOD activity. Enzymatic activity was defined by regions of clearing in a background of black precipitate. The bands were quantified by densitometry using NIH Image software. Subcellular localization of ectopically expressed MnSOD and Cu/ZnSOD in rat heart cells. Immunofluorescent localization of recombinant Cu/ ZnSOD and MnSOD was performed on a rat-heart-derived cell line, H9C2. Cells were infected with Ad.Cu/ZnSOD or Ad.MnSOD at an m.o.i. of 1500 particles/cell. Cells were fixed in 3.7% formaldehyde for 15 min at 37°C at 24 h postinfection. The cells were then permeabilized using 0.2% Triton X-100 for 5 min at room temperature. Following blocking in 20% donkey serum/PBS for 20 min, the slides were incubated in sheep anti-human Cu/ZnSOD or MnSOD antibody (The Binding Site, Birmingham, United Kingdom) for 30 min at room temperature. Antigens were detected by indirect immunofluorescence using 4 g/ml donkey anti-sheep Alexa Fluor 594 second antibody (Molecular Probes). Mitochondria were then stained in 20 nM MitoFluor Green (Molecular Probes).
Statistical analysis. ANOVA was used to assess significant differences between three or more groups of experimental conditions. The Student t test was then used to analyze differences between two groups. A P Ͻ 0.05 was considered significant for both ANOVA and the Student t test. Results are reported as the means Ϯ SEM.
